BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17353701)

  • 1. Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
    Almeida JA; Riordan SM; Liu J; Galhenage S; Kim R; Bihari D; Wegner EA; Cranney GB; Thomas PS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):341-6. PubMed ID: 17353701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatopulmonary syndrome.
    Aboussouan LS; Stoller JK
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):1033-48. PubMed ID: 11139353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatopulmonary syndrome in liver cirrhosis].
    Culafić Dj; Perisić M; Rebić P
    Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of hepatopulmonary syndrome with elevated exhaled nitric oxide].
    Hamamoto J; Toba S; Hirosako S; Nakamura K; Fujii K; Kohrogi H
    Nihon Kokyuki Gakkai Zasshi; 2010 May; 48(5):379-84. PubMed ID: 20560441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents.
    Añel RM; Sheagren JN
    Clin Infect Dis; 2001 May; 32(10):E131-6. PubMed ID: 11317264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatopulmonary syndrome in children.
    Noli K; Solomon M; Golding F; Charron M; Ling SC
    Pediatrics; 2008 Mar; 121(3):e522-7. PubMed ID: 18310172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis.
    Rolla G; Brussino L; Colagrande P; Dutto L; Polizzi S; Scappaticci E; Bergerone S; Morello M; Marzano A; Martinasso G; Salizzoni M; Bucca C
    Hepatology; 1997 Oct; 26(4):842-7. PubMed ID: 9328302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatopulmonary syndrome.
    Gaines DI; Fallon MB
    Liver Int; 2004 Oct; 24(5):397-401. PubMed ID: 15482333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome.
    Gómez FP; Barberà JA; Roca J; Burgos F; Gistau C; Rodríguez-Roisin R
    Hepatology; 2006 May; 43(5):1084-91. PubMed ID: 16628648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome.
    Fallon MB
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S138-42. PubMed ID: 15758649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatopulmonary syndrome characteristics in hepatic cirrhosis associated with COPD].
    Nevzorova VA; Pestrikova TL; Kochetkova EA; Osvald M; Doutreleau S; Massard G
    Ter Arkh; 2009; 81(3):15-9. PubMed ID: 19459415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy Insight: hepatopulmonary syndrome and orthotopic liver transplantation.
    Pastor CM; Schiffer E
    Nat Clin Pract Gastroenterol Hepatol; 2007 Nov; 4(11):614-21. PubMed ID: 17978818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatopulmonary syndrome-discussion of cardiopulmonary parameters.
    Miki K; Shinohara T; Ogushi F; Sone S; Yamada H; Oishi Y; Wakatsuki T; Ito S; Yogita S; Tashiro S
    J Med Invest; 2000 Aug; 47(3-4):164-9. PubMed ID: 11019499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy.
    Shawcross DL; Davies NA; Mookerjee RP; Hayes PC; Williams R; Lee A; Jalan R
    Hepatology; 2004 Feb; 39(2):471-5. PubMed ID: 14768000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of contrast echocardiography and lung perfusion scan in detecting intrapulmonary vascular dilatation in normoxemic patients with early liver cirrhosis.
    Mimidis KP; Vassilakos PI; Mastorakou AN; Spiropoulos KV; Lambropoulou-Karatza CA; Thomopoulos KC; Tepetes KN; Nikolopoulou VN
    Hepatogastroenterology; 1998; 45(24):2303-7. PubMed ID: 9951913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene blue improves the hepatopulmonary syndrome.
    Schenk P; Madl C; Rezaie-Majd S; Lehr S; Müller C
    Ann Intern Med; 2000 Nov; 133(9):701-6. PubMed ID: 11074903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatopulmonary syndrome].
    Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
    Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in hepatopulmonary syndrome.
    Wang YW; Lin HC
    J Chin Med Assoc; 2005 Nov; 68(11):500-5. PubMed ID: 16323392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatopulmonary syndrome: physiopathology of impaired gas exchange].
    Robert V; Chabot F; Vial B; Guiot P; Poussel JF; Polu JM
    Rev Mal Respir; 1999 Nov; 16(5):769-79. PubMed ID: 10612146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatopulmonary syndrome. A review of the literature.
    Ghittoni G; Valentini G; Spada C; Rossi Z; Gasbarrini G
    Panminerva Med; 2003 Jun; 45(2):95-8. PubMed ID: 12855933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.